Alzheimer’s Disease & Dementia

Alzheimer’s Disease

Cannabinoids remove plaque-forming Alzheimer’s proteins from brain cells Science Daily (2016)

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease Frontiers in Pharmacology (2020)

Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer’s disease Complementary Therapies in Medicine (2021)

Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease MDPI (2021)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease Frontiers in Neuroscience (2022)

Oral THC: CBD cannabis extract in main symptoms of Alzheimer’s disease: agitation and weight loss Clinical Therapeutics (2023)

Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration MDPI (2023)


Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis The Canadian Journal of Psychiatry (2019)

Cannabinoids in the management of frontotemporal dementia: a case series Future Medicine (2020)

Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial Frontiers in Medicine (2022)

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients Frontiers in Aging Neuroscience (2022)